Respiratory paralysis to improve oxygenation and mortality in large newborn infants with respiratory distress.
The nonsynchronous respiratory efforts of neonates with surgically correctable disorders may inhibit effective mechanical ventilation. The records of 25 infants treated with metocurine for muscular paralysis to improve mechanical ventilation were reviewed. All patients were greater than 35 (37.6 +/- 2.1) weeks gestation and 2.27 (2.98 +/- .47) kg. All required ventilatory support with an FiO2 of 100%. The mortality rate of this group of infants was 20% as compared with 73% (p < .001) in a similar group of 26 infants managed without paralysis. In 10 of the 25 infants treated with metocurine, pre- and 1 hr postparalysis paO2 values were available. The mean paO2 prior to paralysis was 62 (45--111) mm Hg and the mean post-paralysis paO2 was 144 (75--227) mm Hg, representing at 132% increase in paO2 (p < .001). The mean dosage for metocurine was 3.5 (1.45--6.79) mg/kg/day; however, those requiring paralysis for greater than 7 days showed a dramatically increasing requirement. These preliminary data suggest that respiratory paralysis reduces right-to-left shunting, improves paO2 and decreases mortality in large infants with severe respiratory distress requiring ventilatory support.
D003964:Diaphragm / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D007366:Intercostal Muscles / Q000187:drug effects*; D010100:Oxygen / Q000097:blood*; D010547:Persistent Fetal Circulation Syndrome / Q000628:therapy; D012121:Respiration, Artificial / Q000379:methods; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood / Q000401:mortality / Q000628:therapy*; D014403:Tubocurarine / Q000031:analogs & derivatives* / Q000494:pharmacology
D010100:Oxygen; C032943:metocurine; D014403:Tubocurarine